journal article·2021-06

Thiophene donor for NIR-II fluorescence imaging-guided photothermal/photodynamic/chemo combination therapy

Qiang Liu, Jiangwei Tian, Ye Tian, Qinchao Sun, Dan Sun, Dewen Liu, Feifei Wang, Haijun Xu, Guoliang Ying, Jigang Wang, Ali K. Yetisen, Nan Jiang

Acta Biomaterialia· Volume 127
Publisher page

Abstract

Organic fluorophores/photosensitizers have been widely used in biological imaging and photodynamic and photothermal combination therapy in the first near-infrared (NIR-I) window. However, their applications in the second near-infrared (NIR-II) window are still limited primarily due to low fluorescence quantum yields (QYs). Here, a boron dipyrromethene (BDP) is created as a molecularly engineered thiophene donor unit with high QYs to the redshift. Thiophene insertion initiates substantial redshifts of the absorbance as compared to its counterparts in which iodine is introduced. The fluorescent molecule can be triggered by an NIR laser with a single wavelength, thereby producing emission in the NIR-II windows. Single NIR laser-triggered phototherapeutic nanoparticles (NPs) are developed by encapsulating the BDP and the chemotherapeutic drug docetaxel (DTX) by using a synthetic amphiphilic poly(styrene-co-chloromethyl styrene)-graft-poly(ethylene glycol) functionalized with folic acid (FA). These BDP-T-N-DTX-FA NPs not only show superior solubility and high singlet oxygen QY (ΦΔ=62%) but also demonstrate single NIR laser-triggered multifunctional characteristics. After intravenous administration of the NPs into 4T1 tumor-bearing mice, the accumulation of the NPs in the tumor showed a high signal-to-background ratio (11.8). Furthermore, 4T1 tumors in mice were almost eradicated by DTX released from the BDP-T-N-DTX-FA NPs under single NIR laser excitation and the combination of photodynamic therapy (PDT) and photothermic therapy (PTT). STATEMENT OF SIGNIFICANCE: The application of organic photosensitizers is still limited primarily due to low fluorescence quantum yields (QYs) in the second near-infrared (NIR-II) window. Here, a boron dipyrromethene (BDP) as a molecularly engineered thiophene donor unit with high QYs to the redshift is created. Phototherapeutic nanoparticles (NPs) are developed by encapsulating the BDP and docetaxel (DTX) using a synthetic amphiphilic poly(styrene-co-chloromethyl styrene)-graft-poly(ethylene glycol) functionalized with folic acid (FA). These BDP-T-N-DTX-FA NPs not only show high singlet oxygen QY (ΦΔ=62%) but also demonstrate single NIR laser-triggered multifunctional characteristics and a high signal-to-background ratio (11.8). Furthermore, 4T1 tumors in mice were almost eradicated by DTX released from the BDP-T-N-DTX-FA NPs under single NIR laser excitation and the PDT/PTT combination therapy.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (49)

Show source-provided references
1. Multifunctional theranostic nanoplatform for cancer combined therapy based on gold nanorods10.1002/adhm.201500453 ↗
2. Black titania-based theranostic nanoplatform for single NIR laser induced dual-modal imaging-guided PTT/PDT10.1016/j.biomaterials.2016.01.009 ↗
3. Dendrimer-encapsulated naphthalocyanine as a single agent-based theranostic nanoplatform for near-infrared fluorescence imaging and combinatorial anticancer phototherapy10.1039/C4NR06050D ↗
4. Organic dye based nanoparticles for cancer phototheranostics10.1002/smll.201704247 ↗
5. Cell membrane coated semiconducting polymer nanoparticles for enhanced multimodal cancer phototheranostics10.1021/acsnano.8b04066 ↗
6. Highly stable organic small molecular nanoparticles as an advanced and biocompatible phototheranostic agent of tumor in living mice10.1021/acsnano.7b03062 ↗
7. One-step assembly of CuMo2S3 nanocrystals for the synergistic effect of photothermal therapy and photodynamic therapy10.1039/C7DT04901C ↗
8. All-in-one phototheranostics: single laser triggers NIR-II fluorescence/photoacoustic imaging guided photothermal/photodynamic/chemo combination therapy10.1002/adfm.201901480 ↗
9. Ultralow-power near infrared lamp light operable targeted organic nanoparticle photodynamic therapy10.1021/jacs.6b05390 ↗
10. Functionalized flexible soft polymer optical fibers for laser photomedicine10.1002/adom.201701118 ↗
11. A bright organic NIR-II nanofluorophore for three-dimensional imaging into biological tissues10.1038/s41467-018-03505-4 ↗
12. Bright quantum dots emitting at ~1,600 nm in the NIR-IIb window for deep tissue fluorescence imaging10.1073/pnas.1806153115 ↗
13. Molecular imaging in the second near-infrared window10.1002/adfm.201900566 ↗
14. Chlorin e6 conjugated poly(dopamine) nanospheres as PDT/PTT dual-modal therapeutic agents for enhanced cancer therapy10.1021/acsami.5b01027 ↗
15. NIR-II light activated photodynamic therapy with protein-capped gold nanoclusters10.1007/s12274-017-1917-4 ↗
16. Multifunctional supramolecular vesicles for combined photothermal/photodynamic/hypoxia-activated chemotherapy10.1039/C8CC05560B ↗
17. Enhanced efficacy of photothermal therapy by combining a semiconducting polymer with an inhibitor of a heat shock protein10.1039/C8QM00459E ↗
18. Nitroreductase-activatable theranostic molecules with high PDT efficiency under mild hypoxia based on a TADF fluorescein derivative10.1021/acsami.9b04488 ↗
19. In vivo singlet molecular oxygen measurements: sensitive to changes in oxygen saturation during PDT10.1016/j.pdpdt.2018.07.006 ↗
20. Development of organic semiconducting materials for deep-tissue optical imaging, phototherapy and photoactivation10.1039/C8CS00001H ↗
21. Antitumor immunity triggered by photothermal therapy and photodynamic therapy of a 2D MoS2 nanosheet-incorporated injectable polypeptide-engineered hydrogel combinated with chemotherapy for 4T1 breast tumor therapy10.1088/1361-6528/ab72b9 ↗
22. Local biomaterials-assisted cancer immunotherapy to trigger systemic antitumor responses10.1039/C9CS00271E ↗
23. NIR light-activated drug release for synergetic chemo–photothermal therapy10.1021/acs.molpharmaceut.6b00820 ↗
24. NIR-triggered drug release from switchable rotaxane-functionalized silica-covered Au nanorods10.1039/C4CC02966F ↗
25. Tuning the photo-physical properties of BODIPY dyes: effects of 1, 3, 5, 7-substitution on their optical and electrochemical behaviours10.1016/j.dyepig.2019.04.054 ↗
26. BODIPY-doped silica nanoparticles with reduced dye leakage and enhanced singlet oxygen generation
27. Donor engineering for NIR-II molecular fluorophores with enhanced fluorescent performance10.1021/jacs.7b10334 ↗
28. Cell-specific and pH-activatable rubyrin-loaded nanoparticles for highly selective near-infrared photodynamic therapy against cancer10.1021/ja408286k ↗
29. In vitro photodynamic studies of a BODIPY based photosensitizer10.1002/ejoc.201601054 ↗
30. Deep-tissue anatomical imaging of mice using carbon nanotube fluorophores in the second near-infrared window10.1073/pnas.1014501108 ↗
31. Chlorin e6 conjugated copper sulfide nanoparticles for photodynamic combined photothermal therapy10.1016/j.pdpdt.2017.04.005 ↗
32. Engineering of tungsten carbide nanoparticles for imaging-guided single 1,064 nm laser-activated dual-type photodynamic and photothermal therapy of cancer10.1007/s12274-018-2075-z ↗
33. Temperature-feedback upconversion nanocomposite for accurate photothermal therapy at facile temperature10.1038/ncomms10437 ↗
34. Dual peak absorbing semiconducting copolymer nanoparticles for first and second near infrared window photothermal therapy a comparative study10.1002/adma.201705980 ↗
35. Self-destructive PEG–BODIPY nanomaterials for photodynamic and photothermal therapy10.1039/C9TB00752K ↗
36. Electrospun sulfated silk fibroin nanofibrous scaffolds for vascular tissue engineering10.1016/j.biomaterials.2011.02.002 ↗
37. A theranostic agent for cancer therapy and imaging in the second near-infrared window10.1007/s12274-018-2210-x ↗
38. A theranostic agent for cancer therapy and imaging in the second near-infrared window10.1007/s12274-018-2210-x ↗
39. A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer10.1038/aps.2017.43 ↗
40. Near infrared light-controlled therapeutic molecules release of nanocarriers in cancer therapy10.1007/s40005-017-0321-0 ↗
41. Chemical amplification accelerates reactive oxygen species triggered polymeric degradation10.1039/C7BM00758B ↗
42. ROS-responsive drug delivery systems for biomedical applications10.1016/j.ajps.2017.11.002 ↗
43. ROS-triggered degradation of selenide-containing polymers based on selenoxide elimination10.1039/C9PY00171A ↗
44. Porphyrin photosensitizers in photodynamic therapy and its applications10.18632/oncotarget.20189 ↗
45. Coordination induced assembly of intelligent polysaccharide based phototherapeutic nanoparticles for cancer treatment10.1002/adhm.201600877 ↗
46. A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors10.18632/oncotarget.7143 ↗
47. Noninvasive imaging of immune checkpoint ligand PD-L1 in tumors and metastases for guiding immunotherapy10.1177/1536012117718459 ↗
48. A small-molecule dye for NIR-II imaging10.1038/nmat4476 ↗
49. Targeted zwitterionic near-infrared fluorophores for improved optical imaging10.1038/nbt.2468 ↗